Imatinib Mesylate Therapy in Patients of Chronic Myeloid Leukemia with Philadelphia Chromosome Positive: An Experience from Eastern India

Lignende værker

• Imatinib-induced thyroiditis in Philadelphia chromosome-positive chronic myeloid leukemia
  af: Singh, Surjit, et al.
  Udgivet: (2016)
• Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy
  af: Lippert, Eric, et al.
  Udgivet: (2010)
• Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
  af: Elias, Marjanu Hikmah, et al.
  Udgivet: (2012)
• Multiple copies of BCR-ABL fusion gene on two isodicentric Philadelphia chromosomes in an imatinib mesylate-resistant chronic myeloid leukemia patient
  af: AL-ACHKAR, WALID, et al.
  Udgivet: (2013)
• The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire
  af: Koffi, K. G., et al.
  Udgivet: (2010)